SEC Company Response from Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788) (GLSI) — Apr 4, 2022

Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)
Date: April 4, 2022 · CIK: 0001799788 · Accession: 0001493152-22-009020

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-263855

Date

April 1, 2022

Author

Not clearly detected

Form

CORRESP

Company

Greenwich LifeSciences, Inc. (GLSI) (CIK 0001799788)

Letter

Greenwich LifeSciences, Inc.

Bluebonnet Dr., Building 14

Stafford, TX 77477

April 4, 2022

VIA EDGAR

United States Securities and Exchange Commission

F Street, N.E.

Washington, D.C. 20549

Attention: Gary Guttenberg

Re: Greenwich LifeSciences, Inc.

Amendment No. 1 to Form S-3 Registration Statement

Filed April 1, 2022

File No. 333-263855

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Greenwich LifeSciences, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Daylight Time, on Wednesday, April 6, 2022, or as soon thereafter as possible.

Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

GREENWICH LIFESCIENCES, INC.

By: /s/ Snehal Patel

Name: Snehal Patel

Title: Chief Executive Officer

-1-

Show Raw Text

CORRESP
1
filename1.htm

Greenwich
LifeSciences, Inc.

3992
Bluebonnet Dr., Building 14

Stafford,
TX 77477

    April
    4, 2022

VIA
EDGAR

United
States Securities and Exchange Commission

100
F Street, N.E.

Washington,
D.C. 20549

Attention:
Gary Guttenberg

    Re:
    Greenwich
    LifeSciences, Inc.

    Amendment
    No. 1 to Form S-3 Registration Statement

    Filed
    April 1, 2022

    File
    No. 333-263855

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Greenwich LifeSciences, Inc. (the “Company”)
respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective
at 4:00 p.m., Eastern Daylight Time, on Wednesday, April 6, 2022, or as soon thereafter as possible.

Please
notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible
as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

    GREENWICH
    LIFESCIENCES, INC.

    By:
    /s/ Snehal
    Patel

    Name:
    Snehal
    Patel

    Title:
    Chief
    Executive Officer

     -1-

SecProbe.io